Article
Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria
27 Jan 2022
Abstract excerpt
Heterologous immunity, when the memory T cell response elicited by one pathogen recognizes another pathogen, has been offered as a contributing factor for the high variability in coronavirus disease 2019 (COVID-19) severity outcomes. Here we demonstrate that sensitization with bacterial peptides can induce heterologous immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) derived peptides and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
